Drugs Made In America Acquisition (DMIIU) Cash & Equivalents (2024 - 2026)
Drugs Made In America Acquisition's Cash & Equivalents was $174,974 in Q2 2026.
Powered by 
Analysis
Drugs Made In America Acquisition (DMIIU) Cash & Equivalents (2024 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Drugs Made In America Acquisition came in at $223.00, down 98.7% from FY2024.
- In earlier years, Cash & Equivalents was $17,035 in FY2024.
- Quarterly Cash & Equivalents has moved between $223.00 (Q4 2025) and $315,087 (Q3 2025) over five years.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 174,974.00 |
| Dec 31, 2025 | 223.00 |
| Sep 30, 2025 | 315,087.00 |
| Jun 30, 2025 | 4,394.00 |
| Dec 31, 2024 | 17,035.00 |
API Access
Drugs Made In America Acquisition Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=DMIIU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "DMIIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=DMIIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();